For over thirty years, CRL has delivered personalized service and customized solutions, while quietly growing to become one of the leading laboratories in the world.
Tim Sotos is Chairman of the Board of Clinical Reference Laboratory. He has been Chairman of the Board since 1995 and has been with CRL for over 25 years. He holds a B.S. in Economics and an M.B.A., both from the University of Pennsylvania, Wharton School of Business.
John Martin is the President and CEO of Clinical Reference Laboratory. He previously served as Executive Vice President and Chief Administrative Officer of CRL. Prior to CRL, Mr. Martin held senior executive roles with Viracor-IBT Laboratories, initially serving as Chief Financial Officer and then as President and CEO of Viracor-IBT. Prior to Viracor, Mr. Martin was with George K. Baum & Company, where he served as Managing Director, leading the firm’s middle market investment banking and strategic advisory practice. Mr. Martin’s career also includes 11 years with Fortune 500 companies, including senior management roles with Sprint Corporation and financial management roles with General Electric. Mr. Martin holds a B.S. in Business, Finance from Kansas State University.
Dr. Stout serves as Chief Scientific Officer and Laboratory Director for CRL’s General Laboratory. He provides scientific direction and research leadership for all of CRL with particular focus on research for CRL’s Insurer Services business. Dr. Stout, who has been with CRL since 1983, holds more than ten U.S. Patents in science, including one for immunoassay method and apparatus development (U.S. Patent #4,414,324) and one for methods of determining chronic Hepatitis C infection (U.S. Patent #10,051,253). He is the author of numerous research and review articles and is a regular presenter at scientific meetings and conferences. Dr. Stout holds a B.S. in Biochemistry from California State University and a Ph.D. in Biological Chemistry from U.C.L.A. School of Medicine.
Dr. Fehling has been with CRL since 2008 and is a certified High Complexity Laboratory Director by the American Board of Bioanalysis (ABB). Dr. Fehling leads CRL’s Personalized Medicine business unit and serves as the Laboratory Director for CRL’s Molecular / Esoteric Laboratory. More broadly, Dr. Fehling provides scientific leadership across all business units at CRL with her extensive experience in laboratory management, new assay development, and business development. Prior to CRL she served as the Director of the Genomics Laboratory at Children’s Mercy Hospital, and the Director of Genomics at the Stowers Institute for Medical Research. Dr. Fehling earned her Ph.D. in Molecular Genetics from Texas A&M University. In addition to her HCLD certification, Dr. Fehling is a certified Technical Supervisor in Molecular Diagnostics and a Clinical Consultant by the American Board of Bioanalysis (ABB).
David Porter has been with CRL since 2010 and is responsible for CRL’s Corporate Compliance program, legal operations, and CRL’s corporate quality management and enterprise risk function. He also serves as CRL’s Corporate Secretary. He has over 20 years of experience working with businesses as a lawyer and business consultant. Prior to joining CRL, he spent nine years serving as Assistant General Counsel for a Kansas City healthcare system. Mr. Porter holds a law degree from Notre Dame Law School.
Susan Meyer, who has over 25 years of human resource experience, has been with CRL since 1994 and has served as VP of Human Resources since 2007. She is responsible for the Human Resource operation, which includes leadership development, corporate staffing, employee relations, compensation, benefits, and the company administrative function. Ms. Meyer holds a B.S. in Business Administration from the University of Kansas.
T.J. Sotos leads customer and laboratory operations for CRL, encompassing CRL’s employer, insurer and pharma customers and CRL’s core clinical and toxicology laboratories. He previously served as VP of Employer Customer Operations and Toxicology, overseeing CRL’s toxicology laboratory operations, which provide drugs of abuse and other testing services to employers and other CRL clients. Mr. Sotos has also held supply chain, business development and marketing roles for CRL, having joined the company in 2008. Mr. Sotos holds a B.S. in Business Administration and an M.B.A., both from Southern Methodist University.
Cindi Reding joined Clinical Reference Laboratory (CRL) in 2015 as the Executive Director of IT. She is responsible for leading technology strategy and managing overall IT operations. Cindi is an internationally experienced, business-centric leader that has a proven track record partnering with business leaders to improve service delivery, grow revenue, and reduce operating costs in the healthcare, manufacturing, media, utilities, consulting, and real estate industries. Prior to joining CRL, Cindi was a Director of IT with Blue Cross Blue Shield, Kansas City and the CIO/CTO of Penton Business Media. She has also held technology positions with Boeing, PepsiCo, Aventis and Grant Thornton. Cindi holds a BBA degree in Business Administration from Wichita State University and an MBA with an emphasis in Finance from the University of Missouri.